Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 72, Issue 2, 2009, Pages 304-309

  Patel, Sonal R ^a   Zhong, Hui ^a   Sharma, Ashutosh ^a   Kalia, Yogeshvar N ^b  

^a Vyteris Inc   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

In vivo; Migraine; Transdermal iontophoresis; Zolmitriptan

Indexed keywords

SUMATRIPTAN; ZOLMITRIPTAN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED RELEASE FORMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; NON INVASIVE PROCEDURE; NONHUMAN; SKIN CULTURE; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IONTOPHORESIS; OXAZOLIDINONES; SEROTONIN AGONISTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SWINE; TRYPTAMINES;

EID: 67349129133     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.08.006     Document Type: Article

References (20)

1. Martin G.R., Robertson A.D., MacLennan S.J., Prentice D.J., Barnett V.J., Buckingham J., Honey A.C., Giles H., and Moncada S. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B1/D receptor partial agonist, 3C11C90 (zolmitriptan)®. Br. J. Pharmacol. 121 (1997) 157-164
2. Dixon R., and Warrander A. The clinical pharmacokinetics of zolmitriptan. Cephalgia 17 Suppl. 18 (1997) 15-20
3. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine - current understanding and treatment. N. Engl. J. Med. 346 (2002) 257-270
4. Tfelt-Hansen P., De Vries P., and Saxena P.R. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60 (2000) 1259-1287
5. 1B/1D agonists. Arch. Int. Med. 161 (2001) 2545-2553
6. Lipton R.B. Acute migraine therapy: do doctors understand what patients with migraine want from therapy?. Headache 39 Suppl. 2 (1999) S20-S26
7. Duquesnoy C., Mamet J.P., Sumner D., and Fuseau E. Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur. J. Pharm. Sci. 6 (1998) 99-104
8. Dooley M., and Faulds D. Rizatriptan: a review of its efficacy in the management of migraine. Drug 58 (1999) 699-723
9. Yates R., Nairn K., Dixon R., and Seaber E. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. J. Clin. Pharmacol. 42 (2002) 1237-1243
10. Welch K.M.A., Mathew N.T., Stone P., and Rosamund W. J. Saiers and D. Gutterman. Tolerability of sumatriptan: clinical trials and post-marketing experience. Celphagia 20 (2000) 687-695
11. Kalia Y.N., Naik A., Garrison J., and Guy R.H. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 619-658
12. Femenía-Font A., Balaguer-Fernández C., Merino V., and López-Castellano A. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength. J. Pharm. Sci. 94 (2005) 2183-2186
13. Femenía-Font A., Balaguer-Fernández C., Merino V., and López-Castellano A. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int. J. Pharm. 323 (2006) 125-130
14. Patel S.R., Zhong H., Sharma A., and Kalia Y.N. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Eur. J. Pharm. Biopharm. 66 (2007) 296-301
15. Siegel S.J., O'Neill C., Dubé L.M., Kaldeway P., Morris R., Jackson D., and Sebree T. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Pharm. Res. 24 (2007) 1919-1926
16. Singh P., Roberts M.S., and Maibach H. Modelling of plasma levels of drugs following transdermal iontophoresis. J. Control. Release 33 (1995) 293-298
17. Sekkat N., Kalia Y.N., and Guy R.H. A biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J. Pharm. Sci. 91 (2002) 2376-2381
18. Dick I.P., and Scott R.C. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 44 (1992) 640-645
19. Seaber E.J., Peck R.W., Smith D.A., Allanson J., Hefting N.R., van Lier J.J., Sollie F.A.E., Werner J., and Jonkman J.H.G. The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers. Br. J. Clin. Pharmacol. 46 (1998) 433-439
20. 1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Clin. Pharmacol. Ther. 63 (1998) 342-353